Neuro-Sys Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Neuro-Sys General Information

Description

Operator of a preclinical research and drug development firm intended to specialize in the pharmacology of neurodegenerative diseases. The company offers advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development, enabling clients to develop new treatments for neurodegenerative diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 410 Chemin Départemental 60
  • 13120 Gardanne
  • France
+33 04
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 410 Chemin Départemental 60
  • 13120 Gardanne
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuro-Sys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Neuro-Sys’s complete valuation and funding history, request access »

Neuro-Sys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a preclinical research and drug development firm intended to specialize in the pharmacology of neurodegenera
Drug Discovery
Gardanne, France
34 As of 2024

Montreal, Canada
 

Marseille, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuro-Sys Competitors (79)

One of Neuro-Sys’s 79 competitors is Kainova Therapeutics, a Venture Capital-Backed company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kainova Therapeutics Venture Capital-Backed Montreal, Canada
Innate Pharma Formerly VC-backed Marseille, France
Inhibrx Formerly VC-backed La Jolla, CA
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Molecular Partners Formerly VC-backed Zurich, Switzerland
You’re viewing 5 of 79 competitors. Get the full list »

Neuro-Sys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuro-Sys Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
BigBooster Accelerator/Incubator
Neptune Accelerator Accelerator/Incubator
To view Neuro-Sys’s complete investors history, request access »

Neuro-Sys Investments (1)

Neuro-Sys’s most recent deal was a Grant with Gain Therapeutics for . The deal was made on 23-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gain Therapeutics 23-Jul-2019 Grant Drug Discovery
To view Neuro-Sys’s complete investments history, request access »

Neuro-Sys FAQs

  • When was Neuro-Sys founded?

    Neuro-Sys was founded in 2013.

  • Where is Neuro-Sys headquartered?

    Neuro-Sys is headquartered in Gardanne, France.

  • What is the size of Neuro-Sys?

    Neuro-Sys has 34 total employees.

  • What industry is Neuro-Sys in?

    Neuro-Sys’s primary industry is Drug Discovery.

  • Is Neuro-Sys a private or public company?

    Neuro-Sys is a Private company.

  • What is Neuro-Sys’s current revenue?

    The current revenue for Neuro-Sys is .

  • Who are Neuro-Sys’s investors?

    BigBooster and Neptune Accelerator have invested in Neuro-Sys.

  • Who are Neuro-Sys’s competitors?

    Kainova Therapeutics, Innate Pharma, Inhibrx, Alnylam Pharmaceuticals, and Molecular Partners are some of the 79 competitors of Neuro-Sys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process